
Protalix CFO to present at two major healthcare investor conferences in September 2026
Protalix BioTherapeutics announced that its CFO, Gilad Mamlok, will participate in two key investor events in New York City from September 14-16, 2026. He will present at the H.C. Wainwright 28th Annual Global Investment Conference and join a firesid...

